1. Home
  2. ORA vs CRSP Comparison

ORA vs CRSP Comparison

Compare ORA & CRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ormat Technologies Inc.

ORA

Ormat Technologies Inc.

N/A

Current Price

$87.98

Market Cap

5.5B

Sector

Utilities

ML Signal

N/A

Logo CRISPR Therapeutics AG

CRSP

CRISPR Therapeutics AG

N/A

Current Price

$38.86

Market Cap

4.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ORA
CRSP
Founded
1965
2013
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Electric Utilities: Central
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
4.8B
IPO Year
2004
2016

Fundamental Metrics

Financial Performance
Metric
ORA
CRSP
Price
$87.98
$38.86
Analyst Decision
Buy
Buy
Analyst Count
14
23
Target Price
★ $116.46
$85.42
AVG Volume (30 Days)
631.3K
★ 1.5M
Earning Date
11-04-2026
11-02-2026
Dividend Yield
★ 0.52%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 1.65
N/A
Revenue
★ $719,267,000.00
$289,590,000.00
Revenue This Year
$20.02
$910.97
Revenue Next Year
N/A
$277.83
P/E Ratio
$55.14
★ N/A
Revenue Growth
N/A
★ 9169.85
52 Week Low
$85.77
$39.80
52 Week High
$146.39
$63.45

Technical Indicators

Market Signals
Indicator
ORA
CRSP
Relative Strength Index (RSI) 43.21 26.78
Support Level $86.41 N/A
Resistance Level $97.89 $60.68
Average True Range (ATR) 2.66 2.46
MACD -0.23 -0.95
Stochastic Oscillator 9.17 0.54

Price Performance

Historical Comparison
ORA
CRSP

About ORA Ormat Technologies Inc.

Ormat Technologies Inc is engaged in the geothermal and recovered energy power business. It is engaged in three business segments: the Electricity Segment. where the company develops, builds, owns, and operates geothermal, solar PV, and recovered energy-based power plants in the United States and geothermal power plants in other countries and sells the electricity generated. Product Segment includes designing, manufacturing, and selling equipment for geothermal and recovered energy-based electricity generation and providing services relating to the engineering, procurement, and construction of geothermal & recovered energy-based power plants. Energy Storage Segment includes owning & operating grid-connected which provide capacity, energy, & ancillary services directly to the electric grid.

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

Share on Social Networks: